13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-14, with 29 holding rows worth $1,857,241,000.
- Accession
- 0001085146-18-002700
- Filer
- CIK 1544773
- Filed
- 2018-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2018
A holdings report, 29 entries on the cover page, a total value of $1,857,241,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,857,241,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 3,652,134 | $179,502,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 3,914,182 | $112,454,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 862,295 | $110,270,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 2,303,455 | $105,613,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 4,443,759 | $101,984,000 | thousands by filing date | |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 5,829,878 | $97,942,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 1,446,333 | $82,441,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 4,827,078 | $82,205,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 4,968,663 | $80,840,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 1,089,523 | $77,334,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 1,646,330 | $75,731,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 13,512,958 | $73,105,000 | thousands by filing date | |
| LUMINEX CORP | 55027E102 | COMMON STOCK | 2,369,008 | $71,805,000 | thousands by filing date | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 1,515,422 | $71,573,000 | thousands by filing date | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 5,038,874 | $70,645,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 3,879,050 | $68,737,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 4,168,092 | $58,979,000 | thousands by filing date | |
| STEMLINE THERAPEUTICS INC | 85858C107 | COM | 2,747,198 | $45,603,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 2,449,184 | $39,750,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 1,045,065 | $38,030,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 5,154,224 | $37,368,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 3,093,690 | $34,526,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 4,539,295 | $28,189,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 1,454,761 | $26,317,000 | thousands by filing date | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 731,909 | $23,911,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 6,044,719 | $22,849,000 | thousands by filing date | |
| SESEN BIO INC | 817763105 | COM | 7,523,296 | $16,175,000 | thousands by filing date | |
| INNOVIVA INC | 45781M101 | COM | 1,002,675 | $15,281,000 | thousands by filing date | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 142,943 | $8,082,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-18-002700 | this filing | 2018-11-14 | acceptance time not in the bulk data set |